1. Home
  2. CINF vs ROIV Comparison

CINF vs ROIV Comparison

Compare CINF & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cincinnati Financial Corporation

CINF

Cincinnati Financial Corporation

SELL

Current Price

$165.81

Market Cap

26.4B

Sector

Finance

ML Signal

SELL

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

SELL

Current Price

$33.23

Market Cap

28.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CINF
ROIV
Founded
1950
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.4B
28.7B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CINF
ROIV
Price
$165.81
$33.23
Analyst Decision
Hold
Strong Buy
Analyst Count
8
13
Target Price
★ $188.83
$48.27
AVG Volume (30 Days)
592.6K
★ 6.7M
Earning Date
10-26-2026
11-09-2026
Dividend Yield
★ 2.27%
N/A
EPS Growth
★ 4.40
N/A
EPS
★ 9.78
N/A
Revenue
★ $12,631,000,000.00
$8,260,000.00
Revenue This Year
$4.77
$530.75
Revenue Next Year
N/A
$685.92
P/E Ratio
$16.94
★ N/A
Revenue Growth
★ 11.41
N/A
52 Week Low
$150.00
$16.89
52 Week High
$194.81
$42.50

Technical Indicators

Market Signals
Indicator
CINF
ROIV
Relative Strength Index (RSI) 45.95 37.75
Support Level $159.43 $33.15
Resistance Level $165.96 $37.59
Average True Range (ATR) 2.29 1.13
MACD 0.63 -0.33
Stochastic Oscillator 61.78 17.72

Price Performance

Historical Comparison
CINF
ROIV

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: